Ascentage Investigative Site #1160

Stony Brook, New York 11794

1 studies enrolling now · 1 studies all time

What they study most

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL

Studies at this site

• A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1) — Recruiting now